Atlas FDA

DEFLUX Injectable Gel

FDA premarket approval P000029/S095 · decided 2022-03-17

Approval details

PMA number
P000029
Supplement
S095
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
DEFLUX Injectable Gel
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Palette Life Sciences
Date received
2022-02-17
Decision date
2022-03-17
Days to decision
28 days
Decision code
OK30
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Santa Barbara, CA
Statement
Additional supplier for sodium hydroxide solution, hydrochloric acid solution and phosphate buffer concentrate.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Barrigel Injectable Gel (K220641)Palette Life Sciences2022-05-26